SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

swepub
 

Search: swepub > Örebro University > Tysk Curt > Journal article > Granulocyte, monocy...

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease : the first 100 patients treated in Scandinavia

Ljung, Tryggve (author)
Karolinska University Hospital
Thomsen, Ole Østergaard (author)
Vatn, Morten (author)
University of Oslo
show more...
Karlén, Per (author)
Karolinska Institutet,Soder Hospital, Stockholm
Karlsen, Lars Norman (author)
Rogaland Hospital, Stavanger
Tysk, Curt (author)
Örebro universitet,Hälsoakademin,Örebro University Hospital
Nilsson, Stefan U. (author)
Kristianstad Hospital
Kilander, Anders (author)
Sahlgrenska University Hospital
Gillberg, Rolf (author)
Sahlgrenska University Hospital
Grip, Olof (author)
Lund University,Lunds universitet,Enheten för kroniska inflammatoriska och degenerativa sjukdomar,Forskargrupper vid Lunds universitet,Chronic Inflammatory and Degenerative Diseases Research Unit,Lund University Research Groups,Malmö University Hospital
Lindgren, Stefan (author)
Lund University,Lunds universitet,Enheten för kroniska inflammatoriska och degenerativa sjukdomar,Forskargrupper vid Lunds universitet,Chronic Inflammatory and Degenerative Diseases Research Unit,Lund University Research Groups,Malmö University Hospital
Befrits, Ragnar (author)
Karolinska Institutet,Karolinska University Hospital
Löfberg, Robert (author)
Karolinska Institutet,Karolinska University Hospital
Thomsen, OO (author)
University of Copenhagen
show less...
 (creator_code:org_t)
2009-07-08
2007
English.
In: Scandinavian Journal of Gastroenterology. - Oslo : Taylor & Francis. - 0036-5521 .- 1502-7708. ; 42:2, s. 221-227
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: Selective leukocyte apheresis is a new type of non-pharmacological treatment for patients with active ulcerative colitis and Crohn's disease. Preliminary data have indicated that this type of therapy is safe and efficacious, and large sham-controlled studies are currently in progress. In Scandinavia, a substantial number of patients with chronic inflammatory bowel disease have already received leukocyte apheresis on a compassionate use basis and the aim of this study was to report the clinical outcome and adverse events in the first patients treated. MATERIAL AND METHODS: Clinical details of the first consecutive 100 patients with inflammatory bowel disease treated with granulocyte, monocyte/macrophage (Adacolumn) apheresis in Scandinavia were prospectively registered. Median length of follow-up was 17 months, (range 5-30). RESULTS: The study population comprised 52 patients with ulcerative colitis, 44 patients with Crohn's disease and 4 patients with indeterminate colitis. In 97 patients the indication for Adacolumn treatment was steroid-refractory or steroid-dependent disease. Clinical remission was attained in 48% of the patients with ulcerative colitis, and an additional 27% had a clinical response to the apheresis treatment. The corresponding figures for patients with Crohn's disease were 41% and 23%, respectively. Complete steroid withdrawal was achieved in 27 out of the 50 patients taking corticosteroids at baseline. Adverse events were reported in 15 patients and headache was most frequently reported (n=7). CONCLUSIONS: Granulocyte, monocyte/macrophage apheresis treatment seems to be a valuable adjuvant therapy in selected patients with refractory inflammatory bowel disease. The risk for toxicity or severe adverse events appears to be low.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Keyword

MEDICINE
MEDICIN
Gastroenterology
Gastroenterologi
Medicine
medicin
inflammatory bowel disease
ulcerative colitis
leukocytes
Crohn's disease
apheresis

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view